Your browser doesn't support javascript.
loading
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer.
Haddish-Berhane, Nahor; Su, Yaming; Russu, Alberto; Thayu, Meena; Knoblauch, Roland E; Mehta, Jaydeep; Xie, John; Gibbs, Eric; Sun, Yu-Nien; Zhou, Honghui.
Afiliação
  • Haddish-Berhane N; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Su Y; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Russu A; Janssen Research & Development, a Division of Janssen Pharmaceutica NV, Beerse, Belgium.
  • Thayu M; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Knoblauch RE; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Mehta J; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Xie J; Janssen Research & Development, LLC, Raritan, New Jersey, USA.
  • Gibbs E; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Sun YN; Cognigen Division, Simulations-Plus Company, Buffalo, New York, USA.
  • Zhou H; Jazz Pharmaceuticals, Philadelphia, Pennsylvania, USA.
Clin Pharmacol Ther ; 115(3): 468-477, 2024 03.
Article em En | MEDLINE | ID: mdl-37776107
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2024 Tipo de documento: Article